Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IMTX · NASDAQ · Biological Products, (No Diagnostic Substances) · Foreign private issuer
Immatics (IMTX) · oqro.io/stocks/IMTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$6.39−0.13 (−1.99%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
No insider trades filed yet
Directors and officers of foreign private issuers have filed insider-trading forms (Form 4) only since 18 March 2026, and holders of 10% or more do not file them, so the insider history here is short and incomplete.
